4.58
price up icon6.02%   0.26
 
loading
전일 마감가:
$4.32
열려 있는:
$4.34
하루 거래량:
331.92K
Relative Volume:
0.62
시가총액:
$166.56M
수익:
$425.17M
순이익/손실:
$-92.21M
주가수익비율:
458.00
EPS:
0.01
순현금흐름:
$-67.42M
1주 성능:
+8.27%
1개월 성능:
+0.00%
6개월 성능:
-51.22%
1년 성능:
-72.26%
1일 변동 폭
Value
$4.34
$4.61
1주일 범위
Value
$4.20
$4.82
52주 변동 폭
Value
$3.95
$22.64

Nevro Corp Stock (NVRO) Company Profile

Name
명칭
Nevro Corp
Name
전화
650-251-0005
Name
주소
1800 BRIDGE PARKWAY, REDWOOD CITY, CA
Name
직원
1,215
Name
트위터
@Nevro_HF10
Name
다음 수익 날짜
2024-11-11
Name
최신 SEC 제출 서류
Name
NVRO's Discussions on Twitter

NVRO을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Medical Devices icon
NVRO
Nevro Corp
4.58 166.56M 425.17M -92.21M -67.42M 0.01
Medical Devices icon
ABT
Abbott Laboratories
118.95 208.18B 41.22B 5.77B 6.49B 2.94
Medical Devices icon
SYK
Stryker Corp
388.14 148.70B 21.97B 3.59B 3.21B 6.74
Medical Devices icon
BSX
Boston Scientific Corp
90.75 133.32B 15.91B 1.79B 1.89B 0.82
Medical Devices icon
MDT
Medtronic Plc
86.27 111.27B 33.00B 4.29B 5.50B 2.71
Medical Devices icon
EW
Edwards Lifesciences Corp
72.07 42.66B 6.60B 4.16B 490.10M 2.34

Nevro Corp Stock (NVRO) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2024-08-09 업그레이드 Citigroup Sell → Neutral
2024-08-08 업그레이드 Wolfe Research Underperform → Peer Perform
2024-08-07 다운그레이드 JMP Securities Mkt Outperform → Mkt Perform
2024-08-07 다운그레이드 JP Morgan Neutral → Underweight
2024-08-07 다운그레이드 Wells Fargo Equal Weight → Underweight
2024-05-22 다운그레이드 Citigroup Neutral → Sell
2024-02-22 다운그레이드 Oppenheimer Outperform → Perform
2024-01-12 다운그레이드 RBC Capital Mkts Outperform → Sector Perform
2023-12-21 다운그레이드 Canaccord Genuity Buy → Hold
2023-07-19 개시 Robert W. Baird Neutral
2023-05-31 개시 RBC Capital Mkts Outperform
2023-05-15 업그레이드 Oppenheimer Perform → Outperform
2023-04-14 개시 Mizuho Neutral
2023-01-17 다운그레이드 Citigroup Buy → Neutral
2023-01-06 다운그레이드 Piper Sandler Neutral → Underweight
2022-12-20 업그레이드 Canaccord Genuity Hold → Buy
2022-12-12 다운그레이드 Wells Fargo Overweight → Equal Weight
2022-10-12 개시 Jefferies Underperform
2022-05-05 업그레이드 Citigroup Neutral → Buy
2022-04-13 재개 Truist Hold
2022-04-06 개시 Wolfe Research Underperform
2022-03-02 재개 BofA Securities Underperform
2022-01-07 다운그레이드 Morgan Stanley Overweight → Equal-Weight
2021-12-06 업그레이드 Wells Fargo Equal Weight → Overweight
2021-11-09 다운그레이드 Truist Buy → Hold
2021-08-05 다운그레이드 Canaccord Genuity Buy → Hold
2021-08-05 다운그레이드 Citigroup Buy → Neutral
2021-08-05 다운그레이드 Piper Sandler Overweight → Neutral
2021-08-05 다운그레이드 Wells Fargo Overweight → Equal Weight
2021-08-05 다운그레이드 William Blair Outperform → Mkt Perform
2021-07-09 다운그레이드 Redburn Buy → Neutral
2021-07-06 다운그레이드 Robert W. Baird Outperform → Neutral
2021-02-02 개시 Piper Sandler Overweight
2020-10-23 개시 Guggenheim Buy
2020-09-02 개시 Robert W. Baird Outperform
2020-06-08 업그레이드 UBS Sell → Neutral
2020-03-05 개시 Citigroup Buy
2020-02-26 업그레이드 Canaccord Genuity Hold → Buy
2020-01-08 개시 SunTrust Buy
2020-01-06 다운그레이드 Oppenheimer Outperform → Perform
2019-11-07 업그레이드 Oppenheimer Perform → Outperform
2019-10-22 개시 Oppenheimer Perform
2019-03-20 업그레이드 BofA/Merrill Neutral → Buy
2019-03-20 업그레이드 Wells Fargo Market Perform → Outperform
2018-11-28 개시 UBS Sell
2018-11-07 다운그레이드 BofA/Merrill Buy → Neutral
2018-11-06 다운그레이드 JP Morgan Overweight → Neutral
2018-11-06 다운그레이드 Morgan Stanley Equal-Weight → Underweight
2018-10-19 다운그레이드 Goldman Neutral → Sell
2018-07-02 다운그레이드 Morgan Stanley Overweight → Equal-Weight
2018-05-08 재확인 Canaccord Genuity Buy
2018-05-08 다운그레이드 Northland Capital Outperform → Market Perform
2018-05-08 다운그레이드 Wells Fargo Outperform → Market Perform
모두보기

Nevro Corp 주식(NVRO)의 최신 뉴스

pulisher
Nov 23, 2024

Nevro Corp. (NYSE:NVRO) Receives Average Recommendation of "Reduce" from Brokerages - MarketBeat

Nov 23, 2024
pulisher
Nov 21, 2024

Nevro Stock Rises on Q3 Earnings Beat, Revenues Decrease Y/Y - MSN

Nov 21, 2024
pulisher
Nov 21, 2024

Nevro’s HFX iQ™ Spinal Cord Technology Receives CE Mark Certification in Europe - TechRound

Nov 21, 2024
pulisher
Nov 20, 2024

NVRO Stock Declines Despite Positive Study Data of Nevro1 System - MSN

Nov 20, 2024
pulisher
Nov 20, 2024

Nevro Stock May Gain on the CE Mark Certification for HFX iQ - MSN

Nov 20, 2024
pulisher
Nov 20, 2024

Nevro secures CE mark for AI-based spinal cord stimulation system - MSN

Nov 20, 2024
pulisher
Nov 19, 2024

Nevro’s SI joint fixation system delivers enhanced stability and fusion for patients - Mass Device

Nov 19, 2024
pulisher
Nov 18, 2024

Nevro announces publication of new data on Nevro1 SI Joint Fusion System - TipRanks

Nov 18, 2024
pulisher
Nov 18, 2024

New Study Demonstrates Multiple Advantages of Nevro1™ | Trending From Our Network - Chicago Star Media

Nov 18, 2024
pulisher
Nov 18, 2024

Nevro Corp announces inducement grants - Medical Buyer

Nov 18, 2024
pulisher
Nov 15, 2024

Nevro Announces New Employee Inducement Grants Under NYSE Rule 303A.08 - Quantisnow

Nov 15, 2024
pulisher
Nov 15, 2024

Engaged Capital LLC Adjusts Its Stake in Nevro Corp - GuruFocus.com

Nov 15, 2024
pulisher
Nov 15, 2024

ARMISTICE CAPITAL, LLC Acquires Additional Shares in Nevro Corp - GuruFocus.com

Nov 15, 2024
pulisher
Nov 14, 2024

Amendment: SEC Form SC 13D/A filed by Nevro Corp. - Quantisnow

Nov 14, 2024
pulisher
Nov 14, 2024

Nevro Corp. Reports Strong Q3 2024 Financial Performance - TipRanks

Nov 14, 2024
pulisher
Nov 14, 2024

Nevro Corp. (NVRO) Quarterly 10-Q Report - Quartzy

Nov 14, 2024
pulisher
Nov 14, 2024

NVRO stock touches 52-week low at $4.35 amid market challenges - Investing.com

Nov 14, 2024
pulisher
Nov 14, 2024

FY2024 Earnings Forecast for Nevro Issued By William Blair - MarketBeat

Nov 14, 2024
pulisher
Nov 14, 2024

Nevro Corp.'s SWOT analysis: stock faces headwinds amid market challenges - Investing.com Australia

Nov 14, 2024
pulisher
Nov 14, 2024

Analysts Are Updating Their Nevro Corp. (NYSE:NVRO) Estimates After Its Third-Quarter Results - Yahoo Finance

Nov 14, 2024
pulisher
Nov 13, 2024

Nevro wins CE mark for spinal cord stimulation technology - BioWorld Online

Nov 13, 2024
pulisher
Nov 13, 2024

FY2026 Earnings Estimate for Nevro Issued By William Blair - MarketBeat

Nov 13, 2024
pulisher
Nov 13, 2024

Nevro stock price target cut, retains hold rating on earnings release - Investing.com Canada

Nov 13, 2024
pulisher
Nov 13, 2024

Nevro Third Quarter 2024 Earnings: Beats Expectations - Yahoo Finance

Nov 13, 2024
pulisher
Nov 13, 2024

Nevro Corp’s Market Cap Challenges: Impairment Risks and Investor Concerns - TipRanks

Nov 13, 2024
pulisher
Nov 12, 2024

Nevro Corp stock target cut, keeps underweight rating on Q3 results - Investing.com

Nov 12, 2024
pulisher
Nov 12, 2024

Nevro wins CE mark for HFX iQ spinal cord stim for pain relief - Mass Device

Nov 12, 2024
pulisher
Nov 12, 2024

Nevro price target raised to $6 from $5 at Baird - TipRanks

Nov 12, 2024
pulisher
Nov 12, 2024

Nevro stock price target cut, retains underweight on earnings beat - Investing.com

Nov 12, 2024
pulisher
Nov 12, 2024

Why Medical Device Firm Nevro Stock Is Trading Higher On TuesdayNevro (NYSE:NVRO) - Benzinga

Nov 12, 2024
pulisher
Nov 12, 2024

Nevro (NYSE:NVRO) Price Target Cut to $7.00 by Analysts at Canaccord Genuity Group - MarketBeat

Nov 12, 2024
pulisher
Nov 12, 2024

Nevro's (NVRO) "Sector Perform" Rating Reiterated at Royal Bank of Canada - MarketBeat

Nov 12, 2024
pulisher
Nov 12, 2024

Peeling Back The Layers: Exploring Nevro Through Analyst Insights - Benzinga

Nov 12, 2024
pulisher
Nov 12, 2024

Piper Sandler Cuts Nevro (NYSE:NVRO) Price Target to $6.00 - MarketBeat

Nov 12, 2024
pulisher
Nov 12, 2024

Nevro Corp. (NYSE:NVRO) Q3 2024 Earnings Call Transcript - MSN

Nov 12, 2024
pulisher
Nov 12, 2024

Nevro (NYSE:NVRO) Price Target Raised to $6.00 - MarketBeat

Nov 12, 2024
pulisher
Nov 12, 2024

Nevro Corp stock target upgraded, neutral rating on margin outlook By Investing.com - Investing.com UK

Nov 12, 2024
pulisher
Nov 12, 2024

Nevro Corp (NVRO) PT Lowered to $6 at Piper Sandler - StreetInsider.com

Nov 12, 2024
pulisher
Nov 12, 2024

Nevro receives CE Mark Certification in Europe for HFX iQ SCS System - TipRanks

Nov 12, 2024
pulisher
Nov 12, 2024

Nevro Corp (NVRO) PT Raised to $6 at Baird - StreetInsider.com

Nov 12, 2024
pulisher
Nov 12, 2024

Nevro's HFX iQ™ Spinal Cord Stimulation with AI Technology Receives CE Mark Certification in Europe, Increasing Product Expansion Globally - PR Newswire

Nov 12, 2024
pulisher
Nov 12, 2024

Nevro Corp (NVRO) PT Lowered to $7 at Canaccord Genuity - StreetInsider.com

Nov 12, 2024
pulisher
Nov 12, 2024

Nevro price target lowered to $6 from $7 at Piper Sandler - TipRanks

Nov 12, 2024
pulisher
Nov 12, 2024

Nevro Corp earnings beat by $0.40, revenue topped estimates - Investing.com Canada

Nov 12, 2024
pulisher
Nov 12, 2024

Nevro stock price target cut, retains underweight on earnings beat By Investing.com - Investing.com UK

Nov 12, 2024
pulisher
Nov 11, 2024

Nevro Corp. Shows Resilience Amidst Revenue Challenges - TipRanks

Nov 11, 2024
pulisher
Nov 11, 2024

Nevro: Q3 Earnings Snapshot - CT Insider

Nov 11, 2024
pulisher
Nov 11, 2024

Nevro Corp. Reports Earnings Results for the Third Quarter Ended September 30, 2024 - Marketscreener.com

Nov 11, 2024

Nevro Corp (NVRO) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
medical_devices STE
$217.47
price up icon 0.65%
medical_devices ZBH
$112.02
price up icon 1.25%
medical_devices PHG
$27.15
price up icon 0.89%
$78.10
price up icon 0.21%
$83.00
price up icon 0.59%
medical_devices EW
$72.07
price up icon 0.73%
자본화:     |  볼륨(24시간):